Navigation Links
Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
Date:7/4/2012

: Ovarian Cancer Therapeutics Market, Spain, Patient Volume, 2011–2020 182

Table 76: Ovarian Cancer Therapeutics Market, Spain, Treatment Usage Patterns, 2011–2020 184

Table 77: Ovarian Cancer Therapeutics Market, Spain, Drug Sales ($m), 2002–2011 187

Table 78: Ovarian Cancer Therapeutics Market, Spain, Drug Sales ($m), 2011–2020 188

Table 79: Ovarian Cancer Therapeutics Market, Japan, Drug Sales ($m), 2002-2011 190

Table 80: Ovarian Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 2002–2011 192

Table 81: Ovarian Cancer Therapeutics Market, Japan, Patient Volume, 2002–2011 194

Table 82: Ovarian Cancer Therapeutics Market, Japan, Treatment Usage Patterns, 2002–2011 196

Table 83: Ovarian Cancer Therapeutics Market, Japan, Sales Value ($m), 2011–2020 201

Table 84: Ovarian Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 2011–2020 203

Table 85: Ovarian Cancer Therapeutics Market, Japan, Patient Volume, 2011–2020 205

Table 86: Ovarian Cancer Therapeutics Market, Japan, Treatment Usage Patterns, 2011–2020 207

Table 87: Ovarian Cancer Therapeutics Market, Japan, Drug Sales ($m), 2002–2011 210

Table 88: Ovarian Cancer Therapeutics Market, Japan, Drug Sales ($m), 2011–2020 211

Table 89: Ovarian Cancer Therapeutics Market, Brazil, Sales Value ($m), 2002–2011 213

Table 90: Ovarian Cancer Therapeutics Market, Brazil, Annual Cost of Therapy ($), 2002–2011 215

Table 91: Ovarian Cancer Therapeutics Market, Brazil, Patient Volume, 2002–2011 216

Table 92: Ovarian Cancer Therapeutics Market, Brazil, Treatment Usage Patterns, 2002–2011 218

Table 93: Ovarian Cancer Therapeutics Market, Brazil, Sales Value ($m), 2011–2020 223

Table 94: Ovarian Cancer Therapeutics Market, Brazil, Annual Cost of Therapy ($), 2011–2020
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine technology :

1. Global Kidney Cancer Drugs Industry
2. Trovagene to Study Trans-Renal KRAS Mutation Detection in Pancreatic Cancer
3. Prostate Cancer Center of New Jersey the Latest Center to Achieve High Honor of ACR-ASTRO Accreditation
4. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
5. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
6. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
7. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
8. Healthscope to commercially launch Circadians Cancers of Unknown Primary Diagnostic Test
9. Pinnacle Biologics and INTERmedic Medical Devices announce strategic manufacturing and distribution agreement for cancer laser technology
10. Breast Cancer Detection and Treatment Recovers Slowly from Big Losses During Recession
11. U.K. Cancer Patient is Worlds First to Benefit from Treatment Combining Elektas New Beam-shaping Innovation and High-speed Arc Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. (OTC ... medical device company that develops and sells high performance ... its rights offering.  In addition, the concurrent temporary reduction ... expired on May 17, 2013. Nephros estimates ... from the rights offering.   A portion of the proceeds ...
(Date:5/23/2013)... May 23, 2013  MGC Diagnostics Corporation (NASDAQ: ... technology company, today scheduled a conference call to discuss ... year 2013, ended April 30, 2013. The call will ... 2013. The Company will report financial results for the ... close on Thursday, May 30, 2013. ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2
... Arcion Therapeutics , a venture backed clinical ... today announced top-line results from a successful Phase 2b ... pain candidate, ARC-4558, in adult patients with painful diabetic ... 2 meeting with the United States Food and Drug ...
... , July 20 Allscripts (Nasdaq: ... selected the Allscripts Community Solution to power Huntington Health ... other health care providers across the San Gabriel Valley to connect ... where they are located or which clinical technologies they use. ...
Cached Medicine Technology:Arcion Therapeutics' Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN) 2Arcion Therapeutics' Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN) 3Arcion Therapeutics' Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN) 4Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 2Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 3Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 4Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 5Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 6Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 7
(Date:5/25/2013)... (PRWEB) May 25, 2013 Communities of ... Texas. It is the fifth largest media market in the ... the number one visitor destination in Texas and a major ... to the American West as it is home to many ... will enjoy from sports to the arts. Residents and locals ...
(Date:5/25/2013)... SATURDAY, May 25 (HealthDay News) -- Many viruses and ... rabies and leptospirosis -- a bacteria-borne illness than can ... lurking at dog parks, according to a veterinarian. ... water and even the air, said Dr. Susan Nelson, ... Health Center. "Many of these serious diseases can be ...
(Date:5/25/2013)... States (PRWEB) May 25, 2013 ... largest underground shelter company in the US and ... underground structures for over 35 years. M.E. and ... U.S. Handbook of NBC Weapon Fundamentals and Shelter ... United States’ bible on shelter engineering. McCarthy is ...
(Date:5/25/2013)... May 25, 2013 Absolute Surgical Specialists, serving ... of the NALA’s businesses throughout the country participating in Shop ... participate in the nationwide event as he understands what military ... in the Army. He said, “I wanted to give something ... serve, but I live here too.” , Shop Local for ...
(Date:5/25/2013)... NY (PRWEB) May 25, 2013 ... problems, ranging from irritable bowel syndrome (IBS) to ... are among the most long-lasting, embarrassing, frustrating and ... natural foods for digestive health have provided ... there are many factors contributing to digestive health ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2
... Pa., Jan. 14 Three Rivers,Pharmaceuticals, LLC finalized ... Pharmaceuticals International (NYSE: VRX ). Valeant is,receiving ... "Adding Infergen to our growing portfolio is ... president and chief executive,officer. "This purchase is only ...
... GREEN BAY, Wis., Jan. 14 Shopko announced plans to ... corner of Broadway and,Dousman Street in downtown Green Bay. The ... that will be the first,major anchor in the 90 million ... is expected to open in fall of 2008., "This ...
... Join Forces to Escape the Mistaken ... Label of Pornography, HOLLYWOOD, ... the promotion of sensual products, sexual education and,relationship improvement is set to ... and singles with seminars and,products to enhance their love lives in a ...
... Forest Hospital,Foundation board of directors presented a merger proposal ... care system for northeastern Illinois,and the surrounding region. The ... hospital boards and would bring together the clinical,strength and ... County.*, As part of the proposal, the Lake ...
... with serious risks, FDA notes , , MONDAY, Jan. 14 (HealthDay ... sclerosis, may also be used for patients with a moderate ... U.S. Food and Drug Administration announced Monday. , But the ... a potentially deadly brain infection, as well as other side ...
... of Illinois have found a simple solution to a problem ... buffers used to maintain the pH of laboratory samples to ... team, headed by chemistry professor Yi Lu, developed a method ... a range of low temperatures. , The study appears this ...
Cached Medicine News:Health News:Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals 2Health News:Shopko Express Coming to Downtown Green Bay 2Health News:The First Annual LOVE L.A. Show Promotes Sensuality, Relationships and Sexual Education 2Health News:Lake Forest Hospital Proposes a New Health Care System in Lake County 2Health News:MS Drug Tysabri Approved for Crohn's Disease 2Health News:MS Drug Tysabri Approved for Crohn's Disease 3Health News:New buffer resists pH change, even as temperature drops 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: